Company
Silence Therapeutics plc (SLN)
Standardized SEC financial data for Silence Therapeutics plc — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001479615 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-98.7%
Return on equity
-142.2%
Free cash flow
-$62.3M
Current ratio
8.72×
EPS (diluted)
$-0.63
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $21.7M | $31.6M | $43.3M | $559K |
| Cost of revenue | $13.5M | $12.9M | $11.8M | $215K |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | — | — | $68.8M | $147.3M | $85.1M |
| Total current assets | — | — |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$57.0M | -$49.5M | -$67.6M | -$62.3M |
| Capital expenditures | $173K | $56K | $211K | $55K |
Get SLN data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/SLN/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/SLN/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"